市场见解

2 ASX tech shares that are rapidly growing

Cettire is an ASX share that is seeing a high level of growth.
The post 2 ASX tech shares that are rapidly growing appeared first on The Motley Fool Australia. –

Key points

Digital ASX shares are achieving strong revenue growth
Both Doctor Care Anywhere and Cettire are seeing triple digit revenue growth
The two stocks are investing and further expanding their addressable markets

There are a select few ASX tech shares that are experiencing a high level of growth year on year.

Businesses that are growing at a very fast pace can often capture investor attention.

Depending on their long-term trajectory, they may end up becoming much larger over time.

Doctor Care Anywhere Plc (ASX: DOC)

The Doctor Care Anywhere share price has fallen more than 60% over the past year to $0.55. But the business has been reporting quick operational growth.

Doctor Care Anywhere is a UK-based telehealth company that wants to provide the best possible patient care and experience through its digital platform. It utilises its relationships with health insurers, healthcare providers and corporate customers to connect with patients to deliver a range of telehealth services.

For the three months to September 2021, the company saw quarter on quarter revenue growth of 21.6% to £5.8 million (A$10.7 million). This was driven by 30.6% growth of consultations to 116,800. Over 65% of consultations were delivered to returning patients.

It has also completed the acquisition of tele-health and tele-mental provider GP2U Telehealth. This expanded its operations to Australia, giving it geographic earnings diversification and another avenue for growth.

Excluding the impact of the acquisition, the ASX tech share has guided that FY21 revenue was going to grow by at least 100%.

It’s also evolving its operating model so that it can offer not just a 15 or 20 minute virtual GP consultation, but also a 20 minute virtual consultation with an advanced nurse practitioner or a ‘quick consult’ where a patient completes a questionnaire to be reviewed by a prescribing clinician, resulting in written advice or a prescription without the need for a real time video or phone consultation.

Cettire Ltd (ASX: CTT)

Cettire is a global online retailer. It offers a large selection of in-demand personal luxury goods through its website, Cettire.com. The ASX share has an extensive catalogue of approximately 1,700 luxury brands and 200,000 products across clothing, shoes, bags and accessories.

The ASX tech share is experiencing rapid growth as more customers shop online due to the e-commerce tailwinds.

For the first four months of FY22 to 31 October 2021, sales revenue soared 172% to $57.8 million year on year, with the number of orders rising 209% to 107,676 and active customers soaring 220% to 158,260.

Cettire said that despite offline stores reopening with restrictions easing, its growth trajectory continues unabated.

The Cettire founder and CEO Dean Mintz said:

The focused investment to further enhance Cettire’s solid foundations is delivering results. Having invested in customer acquisition and executed strongly, October monthly traffic increased 379% year on year. In addition, we are seeing very positive early signs from the migration to our proprietary storefront, with sales growth in “migrated” markets outpacing the company.

But the company is also looking to increase its total addressable market. It is looking to open up more potential revenue by exploring new adjacencies, such as the children’s wear segment that it has recently launched.

Management are focused on operating Cettire to “maximise overall revenue growth”.   

The post 2 ASX tech shares that are rapidly growing appeared first on The Motley Fool Australia.

Should you invest $1,000 in Cettire right now?

Before you consider Cettire, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cettire wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Up 480% in a year: Is it too late to invest in Cettire (ASX:CTT) shares?

Can you guess the best and worst All Ordinaries performers of 2021?

These are the 5 best performing ASX shares of 2021

Down 50%: Broker tips A2 Milk (ASX:A2M) and this ASX share to rebound in 2022

2 small cap ASX shares for 2022 with big potential

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Cettire Limited and Doctor Care Anywhere Group PLC. The Motley Fool Australia has recommended Cettire Limited and Doctor Care Anywhere Group PLC. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!